Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_1

25%

Ph phase_2

75%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

1(25.0%)

Phase 2Efficacy & side effects

3(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(1)

Detailed Status

Completed3

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 11 (25.0%)

Phase 23 (75.0%)

Trials by Status

withdrawn125%

completed375%

Recent Activity

0 active trials

Showing 4 of 4

completedphase_2

A Study To Investigate The Safety, Toleration And Efficacy of PF00610355 In Chronic Obstructive Pulmonary Disease (COPD) Patients.

NCT00808288

withdrawnphase_2

A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic Subjects

NCT00830427

completedphase_1

A Study to Investigate the Effects of PF00610335 on the QT/QTC Interval in Healthy Volunteers

NCT01107054

completedphase_2

Safety, Toleration and Efficacy of Single Inhaled Doses of PF-00610355 in Chronic Obstructive Pulmonary (COPD) Patients.

NCT00783406

Clinical Trials (4)

Showing 4 of 4 trials

NCT00808288Phase 2

A Study To Investigate The Safety, Toleration And Efficacy of PF00610355 In Chronic Obstructive Pulmonary Disease (COPD) Patients.

Completed

NCT00830427Phase 2

A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic Subjects

Withdrawn

NCT01107054Phase 1

A Study to Investigate the Effects of PF00610335 on the QT/QTC Interval in Healthy Volunteers

Completed

NCT00783406Phase 2

Safety, Toleration and Efficacy of Single Inhaled Doses of PF-00610355 in Chronic Obstructive Pulmonary (COPD) Patients.

Completed

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4